Key points are not available for this paper at this time.
Capsule summary: Nasal basal cells are characterized by a diseased phenotype in allergic rhinitis, and in vitro assays demonstrated that this is correlated with impaired barrier formation capacity, highlighting them as an interesting potential therapeutic target.
Ruysseveldt et al. (Fri,) studied this question.